Gene regulation as a potential avenue for the treatment of neurodegenerative disorders

By Brown David R  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 5, 2009-05 ,pp. : 515-524

Informa Healthcare

Access to resources Recommend Favorite

Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders

By Geldenhuys Werner J   Van der Schyf Cornelis J  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 2, 2013-02 ,pp. : 115-129

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases

By Bonfils Claire   Walkinshaw Donald R   Besterman Jeffrey M   Yang Xiang-Jiao   Li Zuomei  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1041-1065

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders - Contemporary Approaches

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 175-183

Bentham Science Publishers

Access to resources Recommend Favorite